Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Amryt in-licenses novel gene therapy platform from UCD

pharmatimesJuly 23, 2018

Tag: UCD , Amryt , gene therapy , Epidermolysis bullosa

PharmaSources Customer Service